InChI=1S/C32H44O10/c1- 16- 10- 25(37- 5) 32(36) 28(39- 16) 41- 22- 12- 19- 6- 7- 21- 20(29(19,3) 13- 23(22) 42- 32) 8- 9- 30(4) 27(18- 11- 26(34) 38- 15- 18) 24(40- 17(2) 33) 14- 31(21,30) 35/h11- 12,16,20- 25,27- 28,35- 36H,6- 10,13- 15H2,1- 5H3/t16- ,20+,21- ,22- ,23- ,24+,25- ,27+,28+,29+,30- ,31+,32+/m1/s1 |
CTLHRQFAFGUEQH-HAVIGHGVSA-N |
[H] [C@@] 12C[C@@] 3(C) C(CC[C@] 4([H] ) [C@] 3([H] ) CC[C@] 3(C) [C@H] ([C@H] (C[C@] 43O) OC(C) =O) C3=CC(=O) OC3) =C[C@@] 1([H] ) O[C@] 1([H] ) O[C@H] (C) C[C@@H] (OC) [C@] 1(O) O2 |
|
Elaeodendron tangenala
(NCBI:txid123414)
|
Found in
xylem
(BTO:0001468).
Previous component: wood;
See:
PubMed
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(1R,2S,3aS,3bR,6aR,7aS,9R,11R,11aS,12aR,13aR,13bS,15aR)- 3a,11a- dihydroxy- 11- methoxy- 9,13a,15a- trimethyl- 1- (5- oxo- 2,5- dihydrofuran- 3- yl)- 2,3,3a,3b,4,5,6a,9,10,11,11a,12a,13,13a,13b,14,15,15a- octadecahydro- 1H,7aH- cyclopenta[7,8]phenanthro[2,3- b]pyrano[3,2- e][1,4]dioxin- 2- yl acetate
|
11195447
|
Reaxys Registry Number
|
Reaxys
|
17547460
|
PubMed citation
|
Europe PMC
|
|